ASAPF Quote, Financials, Valuation and Earnings

Venus Concept, Inc. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of -163.68%. Aurora Spine Corp.'s return on equity of -31.49% beat Venus Concept, Inc.'s return on equity of -1236.95%.

Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Venus Concept, Inc. has an analysts' consensus of -- which suggests that it could grow by 6601.15%. Given that Venus Concept, Inc. has higher upside potential than Aurora Spine Corp., analysts believe Venus Concept, Inc. is more attractive than Aurora Spine Corp..

Aurora Spine Corp. has a beta of 0.218, which suggesting that the stock is 78.218% less volatile than S&P 500. In comparison Venus Concept, Inc. has a beta of -0.111, suggesting its less volatile than the S&P 500 by 111.094%.

Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Venus Concept, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. Venus Concept, Inc. pays out -- of its earnings as a dividend.

Aurora Spine Corp. quarterly revenues are $4.4M, which are smaller than Venus Concept, Inc. quarterly revenues of $13.8M. Aurora Spine Corp.'s net income of -$142K is higher than Venus Concept, Inc.'s net income of -$22.5M. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while Venus Concept, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.81x versus 0.04x for Venus Concept, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of -862.39%. Aurora Spine Corp.'s return on equity of -31.49% beat VolitionRX Ltd.'s return on equity of --.

Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 780%. Given that VolitionRX Ltd. has higher upside potential than Aurora Spine Corp., analysts believe VolitionRX Ltd. is more attractive than Aurora Spine Corp..

Aurora Spine Corp. has a beta of 0.218, which suggesting that the stock is 78.218% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Aurora Spine Corp. quarterly revenues are $4.4M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Aurora Spine Corp.'s net income of -$142K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.81x versus 17.13x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of -1037.17%. Aurora Spine Corp.'s return on equity of -31.49% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2161.97%. Given that Catheter Precision, Inc. has higher upside potential than Aurora Spine Corp., analysts believe Catheter Precision, Inc. is more attractive than Aurora Spine Corp..

Aurora Spine Corp. has a beta of 0.218, which suggesting that the stock is 78.218% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Aurora Spine Corp. quarterly revenues are $4.4M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Aurora Spine Corp.'s net income of -$142K is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.81x versus 7.90x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -3.21% compared to Aurora Spine Corp.'s net margin of 3.93%. Aurora Spine Corp.'s return on equity of -31.49% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Aurora Spine Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 93.3%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Aurora Spine Corp., analysts believe Xtant Medical Holdings, Inc. is more attractive than Aurora Spine Corp..

Aurora Spine Corp. has a beta of 0.218, which suggesting that the stock is 78.218% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Aurora Spine Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aurora Spine Corp. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Aurora Spine Corp. quarterly revenues are $4.4M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Aurora Spine Corp.'s net income of -$142K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Aurora Spine Corp.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aurora Spine Corp. is 0.81x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.